MedPath

Athena Pelvic Muscle Trainer - DUETS Trial

Phase 4
Completed
Conditions
Urinary Incontinence
Registration Number
NCT01073878
Lead Sponsor
Athena Feminine Technologies, Inc.
Brief Summary

The purpose of this study is to determine if the Athena Pelvic Muscle Trainer device effectively treats stress, urge or mixed incontinence in women by strengthening the pelvic floor muscles by collecting data from the patient on the

1. Over Active Bladder Questionnaire

2. The 7-Day Urine Diary questionnaire

This study will also look at whether or not there is an improvement in sexual health after using the device by collecting data frm the patient on the

3. Female Sexual Function Index questionnaire

Detailed Description

This is a Phase IV, prospective, open-label, multi-center, observational study to assess the effectiveness of the Athena PMT to relieve or eliminate the symptoms of female urinary incontinence.

The study will enlist approximately 100 or more Nurse-Practitioners in Women's Health as the principle investigators from community-based primary care centers (OB-GYN, Internal Medicine, Family Practices or Women's Health Centers) who will enroll approximately 500 or more subjects who suffer from urge and/or stress urinary incontinence and who may benefit from strengthening of Kegel muscles of the pelvic floor.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
462
Inclusion Criteria
  1. Women between the ages of 30 and 70 years
  2. Suffer from urge-incontinence, stress incontinence or incontinence of mixed etiology and who may benefit from strengthening Kegel muscles by electrical stimulation
  3. Able to provide informed consent and physically able to comply with protocol requirements.
  4. Experience one or more incontinence episodes per week.
  5. Women of childbearing potential must have a negative urine or blood pregnancy test within 7 days prior to initiation of treatment.
  6. Subject may be post-menopausal, surgically sterilized, or willing to use acceptable methods of birth control (e.g., hormonal contraceptive, intra- uterine device (IUD), diaphragm with spermicide, condom with spermicide or abstinence) from the screening visit through the duration of study participation.
  7. Have a positive response to two or more questions on the Athena Questionnaire
Exclusion Criteria
  1. Neurological deficiency that does not permit proper sensory perception or stimulation.
  2. Is currently pregnant, lactating or attempting to get pregnant
  3. Has a cardiac pacemaker or a history of rate or conductive disturbance
  4. Has anatomical vaginal structures that do not permit proper and complete placement of the trainer.
  5. Has irregular menstrual bleeding cycles.
  6. Has urinary or vaginal infections, localized lesions, or other undiagnosed symptoms.
  7. Has a history or symptoms of urinary retention.
  8. Has cancer or a life expectancy of less than one year
  9. Recreational drug use
  10. Consume more than three caffeine beverages daily
  11. Consume more than 1-2 alcoholic drinks per day
  12. Significant drug use (causing diuresis or urinary retention
  13. Allergy or sensitivity to materials in the Athena PMT
  14. Participation in another clinical trial within past 3 months
  15. Subjects morbidly obese (BMI >35)
  16. Subjects who chronically smoke (> 10 cigarettes per day)
  17. Subjects required to do heavy lifting (> 40 pounds regularly)
  18. Surgery within the past six months for incontinence, or use of other incontinence devices
  19. Currently taking cholinergic or anti-cholinergic drugs or other prescription or non-prescription drugs that may increase or decrease the volume or frequency of urination and thus, may confound the results of this study, except, in the opinion of the investigator. The subject's regimen has been stable for at least sixty days.
  20. Suspected infection or condition (e.g., diabetes) that would alter the subjects ability to participate or would confound the results of the trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
To assess objective treatment outcomes of urge, stress or mixed incontinence.5 Visits over 13 weeks. Subjects are seen in the office at Screening Visit 1 (Week -1), Visit 1a (Week 0), Visit 2 (Week 2), Visit 3 (Week 6), Visit 4 (Week 12)

Outcomes will be measured via patient questionnaires over a 13 week trial. Visit 1 (Week -1) and Visit 4 (Week 12) values for the Overactive Bladder Questionnaire and the Female Sexual Function Index will be captured. 7-day Urine Diaries will be captured for the week preceeding visits 2, 3 and 4.

Secondary Outcome Measures
NameTimeMethod
Evaluate effectiveness, tolerability, satisfaction and compliance of the Athena PMT across a wide demographic population using: 1) the Subject Satisfaction Evaluation questionnaireAt Visit 4 (Week 12)

At the last visit, patients will complete a Subject Satisfaction Survey.

Trial Locations

Locations (97)

Kathryn Cervi

🇺🇸

Columbia, Maryland, United States

Holly Murphy

🇺🇸

Columbus, Ohio, United States

Columbus OB/Gyn Inc.

🇺🇸

Columbus, Ohio, United States

Susan Frost

🇺🇸

Columbus, Ohio, United States

Laura C. Maw

🇺🇸

Lehi, Utah, United States

Rand Gynecology, LLC

🇺🇸

Chesapeake, Virginia, United States

Primary Care, PLLC

🇻🇮

Christiansted, Virgin Islands (U.S.)

Patrice C Malena

🇺🇸

Newport News, Virginia, United States

Betsy Browning

🇺🇸

Bennington, Vermont, United States

Kimberly Scheer

🇺🇸

Vashon, Washington, United States

Ocean Beach Women's Clinic

🇺🇸

Ilwaco, Washington, United States

D. Crawford Allison MD

🇺🇸

Waco, Texas, United States

Anne L Stephens

🇺🇸

Chesapeake, Virginia, United States

Kathy Edwards

🇺🇸

Minot, North Dakota, United States

John Foster MD

🇺🇸

Birmingham, Alabama, United States

La Mamma Spa

🇺🇸

Birmingham, Alabama, United States

Evan Vapnek MD

🇺🇸

San Diego, California, United States

Urology Associates, P.C.

🇺🇸

Nashville, Tennessee, United States

Christopher J. Jayne, MD, FACOG

🇺🇸

Houston, Texas, United States

Urology San Antonio

🇺🇸

San Antonio, Texas, United States

Marney Kidwell RNC

🇺🇸

San Antonio, Texas, United States

Julie Spencer

🇺🇸

Lansdowne, Virginia, United States

Kyle Chavers MD

🇺🇸

Dothan, Alabama, United States

Salud! for Women

🇺🇸

Casa Grande, Arizona, United States

Arcadia Well Woman

🇺🇸

Scottsdale, Arizona, United States

Patricia A Faust

🇺🇸

Tempe, Arizona, United States

Teresa Mote RNC NP

🇺🇸

Tucson, Arizona, United States

Lynda Reed

🇺🇸

Ontario, California, United States

Beth Andresen

🇺🇸

Tucson, Arizona, United States

Healthworks

🇺🇸

San Luis Obispo, California, United States

Maureen Allen

🇺🇸

Northglenn, Colorado, United States

Rose Mary Mosher

🇺🇸

Rolling Hills Est., California, United States

Brenda Hanson-Smith, RN, DNS, OGNP

🇺🇸

El Dorado Hills, California, United States

Marilyn Brooks

🇺🇸

San Jacinto, California, United States

Kristan Langdon, ANP-C

🇺🇸

Parker, Colorado, United States

Merrilyn H. McNatt APRN

🇺🇸

New London, Connecticut, United States

Karen D. Adamson

🇺🇸

Salida, Colorado, United States

Jean Ohliger APRN

🇺🇸

South Windsor, Connecticut, United States

Arlena Falcon

🇺🇸

Blountstown, Florida, United States

Carl Spirazza

🇺🇸

Boynton Beach, Florida, United States

Ivonne M. Reynolds

🇺🇸

Margate, Florida, United States

Susan Chappuis, ARNP-C

🇺🇸

Ormond Beach, Florida, United States

Khadra Mohamoud Osman mD

🇺🇸

Ft. Lauderdale, Florida, United States

Bayside Gynecology, P.A.

🇺🇸

Venice, Florida, United States

Shelly E Kramer ARNP

🇺🇸

Lake Worth, Florida, United States

Elizabeth Tsarnas

🇺🇸

Stuart, Florida, United States

Jeffrey C Seiler, MD

🇺🇸

West Palm Beach, Florida, United States

Michael D Benson

🇺🇸

Deerfield, Illinois, United States

Elizabeth Killebrew MD

🇺🇸

Fayetteville, Georgia, United States

Sherry Owen, APN

🇺🇸

Gurnee, Illinois, United States

Deborah Cothran WHNP-BC

🇺🇸

Albany, Georgia, United States

Laurie Knoke

🇺🇸

DeKalb, Illinois, United States

Julie Snow

🇺🇸

Park Ridge, Illinois, United States

Tammi K Herkey

🇺🇸

Bossier City, Louisiana, United States

Kathryn A. Copeland

🇺🇸

Carmel, Indiana, United States

Matthew Sprunger MD

🇺🇸

Fort Wayne, Indiana, United States

Tamara Meisel ARNP

🇺🇸

Lakin, Kansas, United States

Richard F. Ford MD

🇺🇸

Ashland, Kentucky, United States

Elizabeth P Sipala

🇺🇸

Galena, Maryland, United States

Steven Lenowitz, MD

🇺🇸

Bel Air, Maryland, United States

Deborah A. Davis, MSN, CRNP

🇺🇸

Prince Frederick, Maryland, United States

Pioneer Valley Urology

🇺🇸

Springfield, Massachusetts, United States

Martha Klay

🇺🇸

Gt. Barrington, Massachusetts, United States

Margaret Duggan

🇺🇸

Walpole, Massachusetts, United States

Kathleen M. Young RNC NP

🇺🇸

Kalispell, Montana, United States

Isabel M Raposo

🇺🇸

Riverview, Michigan, United States

Kathryn Koches

🇺🇸

Dearborn, Michigan, United States

Mickie G. Autry PhD, NP-C

🇺🇸

Jackson, Mississippi, United States

Women's Health Care Specialists, PC

🇺🇸

Paw Paw, Michigan, United States

Laura Hintz

🇺🇸

Saginaw, Michigan, United States

Meredith Schledorn

🇺🇸

Cortland, New York, United States

Jeanne Ann Dahl, RNC, WHNP

🇺🇸

Albany, New York, United States

Women's Total Health

🇺🇸

Hamburg, New Jersey, United States

Cindy Nevara APN

🇺🇸

Vineland, New Jersey, United States

Lynda M. Adamson

🇺🇸

Galloway, New Jersey, United States

Urogynecology Arts of New Jersey

🇺🇸

East Brunswick, New Jersey, United States

Raj Mahajan MD

🇺🇸

Oswego, New York, United States

Diane Stonemetz

🇺🇸

W. Seneca, New York, United States

Amy G Brenner M.D

🇺🇸

Fairfield, Ohio, United States

Elizabeth D. Allen CNP

🇺🇸

Gallipolis, Ohio, United States

Deborah Malone

🇺🇸

Bend, Oregon, United States

Anne Marie Moore, Womens Health Nurse Practitioner

🇺🇸

Eugene, Oregon, United States

Cathleen Ann Folk FNP

🇺🇸

Portland, Oregon, United States

William Shuler, MD

🇺🇸

Tulsa, Oklahoma, United States

Mary L Hagood, FNP-C

🇺🇸

Roseburg, Oregon, United States

Marie T Ziegler

🇺🇸

West Chester, Pennsylvania, United States

Paulette Schreiber, CRNP

🇺🇸

St. Mary's, Pennsylvania, United States

Institute for Female Pelvic Medicine

🇺🇸

Allentown, Pennsylvania, United States

Nancy Newman RNC, WHNP

🇺🇸

Lexington, South Carolina, United States

John Pickel MD

🇺🇸

Arlington, Texas, United States

Agnes Oblas APRN

🇺🇸

Phoenix, Arizona, United States

Stefanie A Schultis

🇺🇸

Covington, Louisiana, United States

Barbara Wiggin PhD, ANP-C

🇺🇸

Peoria, Arizona, United States

Sharon Little

🇺🇸

Collierville, Tennessee, United States

Margaret A. Hull

🇺🇸

Franklin, Tennessee, United States

New Horizons Women's Care

🇺🇸

Chandler, Arizona, United States

Women's Care Center

🇺🇸

Lexington, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath